490 related articles for article (PubMed ID: 27861749)
1. The challenges of tumor genetic diversity.
Mroz EA; Rocco JW
Cancer; 2017 May; 123(6):917-927. PubMed ID: 27861749
[TBL] [Abstract][Full Text] [Related]
2. Cancer heterogeneity: converting a limitation into a source of biologic information.
Rübben A; Araujo A
J Transl Med; 2017 Sep; 15(1):190. PubMed ID: 28886708
[TBL] [Abstract][Full Text] [Related]
3. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
[TBL] [Abstract][Full Text] [Related]
4. Intratumor heterogeneity in epigenetic patterns.
Assenov Y; Brocks D; Gerhäuser C
Semin Cancer Biol; 2018 Aug; 51():12-21. PubMed ID: 29366906
[TBL] [Abstract][Full Text] [Related]
5. Not Everyone Fits the Mold: Intratumor and Intertumor Heterogeneity and Innovative Cancer Drug Design and Development.
Dzobo K; Senthebane DA; Thomford NE; Rowe A; Dandara C; Parker MI
OMICS; 2018 Jan; 22(1):17-34. PubMed ID: 29356626
[TBL] [Abstract][Full Text] [Related]
6. Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine.
Hiley C; de Bruin EC; McGranahan N; Swanton C
Genome Biol; 2014 Aug; 15(8):453. PubMed ID: 25222836
[TBL] [Abstract][Full Text] [Related]
7. New insights from the widening homogeneity perspective to target intratumor heterogeneity.
Tong M; Deng Z; Zhang X; He B; Yang M; Cheng W; Liu Q
Cancer Commun (Lond); 2018 May; 38(1):17. PubMed ID: 29764517
[TBL] [Abstract][Full Text] [Related]
8. Intratumor Heterogeneity in Breast Cancer.
Beca F; Polyak K
Adv Exp Med Biol; 2016; 882():169-89. PubMed ID: 26987535
[TBL] [Abstract][Full Text] [Related]
9. Current and future molecular profiling of cancer by next-generation sequencing.
Shibata T
Jpn J Clin Oncol; 2015 Oct; 45(10):895-9. PubMed ID: 26292697
[TBL] [Abstract][Full Text] [Related]
10. Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution.
Ling S; Hu Z; Yang Z; Yang F; Li Y; Lin P; Chen K; Dong L; Cao L; Tao Y; Hao L; Chen Q; Gong Q; Wu D; Li W; Zhao W; Tian X; Hao C; Hungate EA; Catenacci DV; Hudson RR; Li WH; Lu X; Wu CI
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6496-505. PubMed ID: 26561581
[TBL] [Abstract][Full Text] [Related]
11. Intratumor heterogeneity: A new perspective on colorectal cancer research.
Zheng Z; Yu T; Zhao X; Gao X; Zhao Y; Liu G
Cancer Med; 2020 Oct; 9(20):7637-7645. PubMed ID: 32853464
[TBL] [Abstract][Full Text] [Related]
12. Intratumor heterogeneity: nature and biological significance.
Gerashchenko TS; Denisov EV; Litviakov NV; Zavyalova MV; Vtorushin SV; Tsyganov MM; Perelmuter VM; Cherdyntseva NV
Biochemistry (Mosc); 2013 Nov; 78(11):1201-15. PubMed ID: 24460935
[TBL] [Abstract][Full Text] [Related]
13.
Chung WJ; Daemen A; Cheng JH; Long JE; Cooper JE; Wang BE; Tran C; Singh M; Gnad F; Modrusan Z; Foreman O; Junttila MR
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E10947-E10955. PubMed ID: 29203670
[No Abstract] [Full Text] [Related]
14. Adapting clinical paradigms to the challenges of cancer clonal evolution.
Murugaesu N; Chew SK; Swanton C
Am J Pathol; 2013 Jun; 182(6):1962-71. PubMed ID: 23708210
[TBL] [Abstract][Full Text] [Related]
15. Deciphering intratumor heterogeneity using cancer genome analysis.
Ryu D; Joung JG; Kim NK; Kim KT; Park WY
Hum Genet; 2016 Jun; 135(6):635-42. PubMed ID: 27126234
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
[TBL] [Abstract][Full Text] [Related]
17. Somatic evolutionary timings of driver mutations.
Gomez K; Miura S; Huuki LA; Spell BS; Townsend JP; Kumar S
BMC Cancer; 2018 Jan; 18(1):85. PubMed ID: 29347918
[TBL] [Abstract][Full Text] [Related]
18. Clonal evolution and tumor-initiating cells: New dimensions in cancer patient treatment.
Apostoli AJ; Ailles L
Crit Rev Clin Lab Sci; 2016; 53(1):40-51. PubMed ID: 26397062
[TBL] [Abstract][Full Text] [Related]
19. Variability in the Solid Cancer Cell Population and Its Consequences for Cancer Diagnostics and Treatment.
Brychtová V; Valík V; Vojtěšek B
Klin Onkol; 2018; 31(Suppl 2):5-13. PubMed ID: 31023018
[TBL] [Abstract][Full Text] [Related]
20. Translating insights into tumor evolution to clinical practice: promises and challenges.
Fittall MW; Van Loo P
Genome Med; 2019 Mar; 11(1):20. PubMed ID: 30925887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
